If we're going to tackle the skyrocketing cost of prescription drugs, along with so many other issues that are at the top of our community's mind, we need to reform our system and make it work for the people, not special interests and corporations.
Whether there is spec buying or not is not the greatest factor in the high cost of pharmaceuticals.
Pharma companies don't have a direct relationship with consumers, so they're always subjects.
To drive down high drug costs, we need to shine a light on the negotiations between drug manufacturers, middleman negotiators and pharmacies.
Indeed, we must foster cost-saving competition. And that means joining the marketplace of other industrialized countries - not just for the manufacturers who sell drugs, but for consumers as well.
Competition is the best way to ensure prescription drugs are affordable.
Drug manufacturers could afford to sell AIDS drugs in Africa at virtually any discount. The companies said they did not do so because Africa lacked the requisite infrastructure.
It is incomprehensible that drug companies still get away with charging Americans twice as much, or more, than citizens of Canada or Europe for the exact same drugs manufactured by the exact same companies.
